Grading cardiac response in AL amyloidosis: implications for relapse and survival

Br J Haematol. 2019 Jul;186(1):144-146. doi: 10.1111/bjh.15717. Epub 2018 Dec 19.

Authors

Erik Eckhert¹, Ronald Witteles¹, Gregory Kaufman¹, Richard Lafayette¹, Sally Arai¹, Stanley Schrier¹, Michelle O'Shaughnessy¹, Michaela Liedtke¹

Affiliation

¹ Department of Medicine, Stanford University Hospital, Stanford, CA, USA.

PMID: 30569572
DOI: 10.1111/bjh.15717

No abstract available

Keywords: amyloidosis; cardiology; clinical aspects.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Cardiomyopathies / etiology
Female
Heart / physiopathology*
Humans
Immunoglobulin Light-chain Amyloidosis / complications*
Immunoglobulin Light-chain Amyloidosis / diagnosis
Immunoglobulin Light-chain Amyloidosis / physiopathology
Male
Neoplasm Recurrence, Local
Prognosis
Recurrence
Survival